Total Payments
$261,654
2024 Payments
$48,973
Companies
38
Transactions
946
Medicare Patients
12,614
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$208,317 (79.6%)
Food & Beverage$22,812 (8.7%)
Travel$17,968 (6.9%)
Consulting$12,075 (4.6%)
Education$382.87 (0.1%)
Gifts$89.00 (0.0%)
Research$10.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $179,817 | 60 | 68.7% |
| Food and Beverage | $22,812 | 798 | 8.7% |
| Honoraria | $22,500 | 4 | 8.6% |
| Travel and Lodging | $17,968 | 55 | 6.9% |
| Consulting Fee | $12,075 | 8 | 4.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,000 | 3 | 2.3% |
| Education | $382.87 | 15 | 0.1% |
| Gift | $89.00 | 2 | 0.0% |
| Unspecified | $10.13 | 1 | 0.0% |
Payments by Type
General
$261,644
945 transactions
Research
$10.13
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $103,865 | 208 | $0 (2024) |
| Sight Sciences, Inc. | $49,378 | 66 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $32,637 | 74 | $0 (2021) |
| Allergan, Inc. | $29,127 | 216 | $0 (2022) |
| EllexiScience | $14,000 | 2 | $0 (2018) |
| Ellex, Inc | $12,089 | 8 | $0 (2018) |
| Alcon Vision LLC | $6,826 | 71 | $0 (2024) |
| Lumenis, Inc | $5,000 | 1 | $0 (2017) |
| Shire North American Group Inc | $1,512 | 9 | $0 (2019) |
| Glaukos Corporation | $1,085 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,973 | 180 | ABBVIE INC. ($28,287) |
| 2023 | $61,211 | 149 | ABBVIE INC. ($46,190) |
| 2022 | $49,213 | 143 | ABBVIE INC. ($29,388) |
| 2021 | $21,646 | 123 | Aerie Pharmaceuticals, Inc. ($9,959) |
| 2020 | $3,788 | 70 | Allergan, Inc. ($1,464) |
| 2019 | $20,295 | 101 | Aerie Pharmaceuticals, Inc. ($12,231) |
| 2018 | $34,729 | 124 | Ellex, Inc ($12,089) |
| 2017 | $21,799 | 56 | EllexiScience ($9,000) |
All Payment Transactions
946 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| 12/09/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| Category: EYE CARE | ||||||
| 11/26/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $24.49 | General |
| 11/21/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: EYE CARE | ||||||
| 11/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: EYE CARE | ||||||
| 11/08/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $30.15 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: EYE CARE | ||||||
| 10/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: EYE CARE | ||||||
| 10/25/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: EYE CARE | ||||||
| 10/24/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: EYE CARE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| XEN-45 GEL STENT VERSUS TRABECULECTOMY IN GLAUCOMA: GOLD-STANDARD PATHWAY STUDY (GPS) | Allergan, Inc. | $10.13 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,406 | 3,684 | $1.1M | $336,057 |
| 2022 | 23 | 2,321 | 2,990 | $945,958 | $243,566 |
| 2021 | 28 | 3,579 | 4,690 | $1.6M | $413,370 |
| 2020 | 29 | 4,308 | 5,794 | $2.0M | $480,629 |
Total Patients
12,614
Total Services
17,158
Medicare Billing
$1.5M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2023 | 54 | 830 | $207,500 | $134,188 | 64.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 363 | 617 | $177,450 | $43,473 | 24.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 336 | 343 | $124,025 | $34,345 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 211 | $46,320 | $15,284 | 33.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 277 | 292 | $80,895 | $14,560 | 18.0% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 17 | 19 | $37,238 | $13,678 | 36.7% |
| 66030 | Injection of medication into eye | Office | 2023 | 55 | 83 | $29,050 | $12,956 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 129 | $45,910 | $12,826 | 27.9% |
| 92250 | Photography of the retina | Office | 2023 | 367 | 380 | $78,234 | $11,485 | 14.7% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 38 | 50 | $79,500 | $11,008 | 13.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 342 | 358 | $50,800 | $10,140 | 20.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 18 | 21 | $33,000 | $6,169 | 18.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 11 | 11 | $24,300 | $4,272 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $9,450 | $2,877 | 30.4% |
| 92134 | Imaging of retina | Office | 2023 | 59 | 76 | $11,350 | $2,513 | 22.1% |
| 68200 | Injection into conjunctiva | Office | 2023 | 25 | 64 | $22,400 | $2,192 | 9.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 12 | 12 | $5,100 | $1,429 | 28.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 20 | 20 | $6,000 | $844.80 | 14.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 38 | 38 | $5,700 | $777.07 | 13.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 32 | 32 | $3,040 | $752.99 | 24.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $1,000 | $188.20 | 18.8% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2023 | 23 | 57 | $855.00 | $98.80 | 11.6% |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2022 | 19 | 280 | $70,000 | $45,370 | 64.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 346 | 563 | $162,240 | $40,916 | 25.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 318 | 331 | $120,075 | $31,943 | 26.6% |
About Dr. Mark Latina, MD
Dr. Mark Latina, MD is a Ophthalmology healthcare provider based in Reading, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801886346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Latina, MD has received a total of $261,654 in payments from pharmaceutical and medical device companies, with $48,973 received in 2024. These payments were reported across 946 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($179,817).
As a Medicare-enrolled provider, Latina has provided services to 12,614 Medicare beneficiaries, totaling 17,158 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Reading, MA
- Active Since 10/26/2005
- Last Updated 12/02/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1801886346
Products in Payments
- DURYSTA (Drug) $93,541
- OMNI SURGICAL SYSTEM (Device) $27,004
- Rhopressa (Drug) $22,727
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $19,826
- OMNI(R) SURGICAL SYSTEM (US) (Device) $19,200
- Tango SLT/Nd: YAG Combination Laser System (Device) $12,089
- LUMIGAN (Drug) $11,365
- rocklatan (Drug) $7,004
- rhopressa (Drug) $4,734
- Rocklatan (Drug) $4,387
- OMNI (Device) $3,138
- XIIDRA (Drug) $1,678
- XEN (Device) $1,306
- VYZULTA (Drug) $646.78
- ALPHAGAN P (Drug) $461.71
- ACTHAR (Biological) $436.87
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $427.91
- TEPEZZA (Drug) $392.70
- Cequa (Drug) $370.33
- XDEMVY (Drug) $284.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.